November 30, 2024 - 19:08

A. Cornelius Baker, a prominent figure in the fight for H.I.V. testing and the rights of individuals affected by H.I.V. and AIDS, has died at the age of 63. Throughout his career, Baker worked tirelessly both within government agencies and as an advocate in the community, focusing on improving the lives of those impacted by the epidemic, particularly among minority populations.
Baker's commitment to public health and social justice was evident in his efforts to increase awareness and access to H.I.V. testing. He believed that education and outreach were crucial in combating the stigma surrounding H.I.V. and AIDS, especially in marginalized communities. His advocacy work helped to shape policies that aimed to provide better healthcare resources and support for individuals living with the virus.
His legacy will be remembered not only for his professional achievements but also for the compassion and dedication he showed to those he served. Baker's passing marks a significant loss in the ongoing struggle for health equity and the rights of people living with H.I.V. and AIDS.
July 30, 2026 - 15:07
Chronically ill people face confusion over new Medicaid work rules and ‘medically frail’ exemptionPatients, advocates, and healthcare experts are raising alarms over the confusion surrounding new Medicaid work requirements and the narrow `medically frail` exemption meant to protect the most...
July 29, 2026 - 21:20
West Nile Virus Detected in Mosquitoes in Coastal GeorgiaHealth officials are urging residents to reach for the bug spray before stepping outside. The Coastal Health District confirmed that three mosquito samples collected in Chatham County have tested...
July 29, 2026 - 01:16
Overlooked plant proteins may boost gut healthFor years, the conversation around gut health has focused on fiber, fermented foods, and probiotics. But a new wave of research is pointing to a different player: overlooked plant proteins. While...
July 28, 2026 - 14:52
An entirely new kind of drug will help us treat the untreatableA groundbreaking medication, the first of its kind to operate through an entirely novel mechanism, has just received approval. Unlike traditional drugs that target proteins, this new approach works...